Connect with us

AI Research

Tenable Research Warns of Critical AI Tool Vulnerability That Requires Immediate Attention [CVE-2025-49596]

Published

on


GUEST RESEARCH:  Tenable Research has identified a critical remote code execution vulnerability (CVE-2025-49596) in Anthropic’s widely adopted MCP Inspector, an open-source tool crucial for AI development. With a CVSS score of 9.4, this flaw leverages default, insecure configurations, leaving organisations exposed by design. MCP Inspector is a popular tool with over 38,000 weekly downloads on npmjs and more than 4,000 stars on GitHub.

Exploitation is alarmingly simple. A visit to a malicious website can fully compromise a workstation, requiring no further user interaction. Attackers can gain persistent access, steal sensitive data, including credentials and intellectual property, and enable lateral movement or deploy malware.

“Immediate action is non-negotiable”, says Rémy Marot, Staff Research Engineer at Tenable. “Security teams and developers should upgrade MCP Inspector to version 0.14.1 or later. This update enforces authentication, binds services to localhost, and restricts trusted origins, closing critical attack vectors. Prioritise robust security policies before deploying AI tools to mitigate these inherent risks.”

For in-depth information about this research, please refer to the detailed blog post published by Tenable’s Research Team.

Please join our community here and become a VIP.

Subscribe to ITWIRE UPDATE Newsletter here
JOIN our iTWireTV our YouTube Community here
BACK TO LATEST NEWS here



Maximising Cloud Efficiency – LUMEN WEBINAR 23 April 2025

According to KPMG, companies typically spend 35% more on cloud than is required to deliver business objectives

The rush to the cloud has led to insufficient oversight, with many organisations struggling to balance the value of cloud agility and innovation against the need for guardrails to control costs.

Join us for an exclusive webinar on Cloud Optimisation.

In this event, the team from Lumen will explain how you can maximise cloud efficiency while reducing cost.

The session will reveal how to implement key steps for effective cloud optimisation.

Register for the event now!


REGISTER!

PROMOTE YOUR WEBINAR ON ITWIRE

It’s all about Webinars.

Marketing budgets are now focused on Webinars combined with Lead Generation.

If you wish to promote a Webinar we recommend at least a 3 to 4 week campaign prior to your event.

The iTWire campaign will include extensive adverts on our News Site itwire.com and prominent Newsletter promotion https://itwire.com/itwire-update.html and Promotional News & Editorial. Plus a video interview of the key speaker on iTWire TV https://www.youtube.com/c/iTWireTV/videos which will be used in Promotional Posts on the iTWire Home Page.

Now we are coming out of Lockdown iTWire will be focussed to assisting with your webinars and campaigns and assistance via part payments and extended terms, a Webinar Business Booster Pack and other supportive programs. We can also create your adverts and written content plus coordinate your video interview.

We look forward to discussing your campaign goals with you. Please click the button below.


MORE INFO HERE!



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

AI Research

Hong Kong start-up IntelliGen AI aims to challenge Google DeepMind in drug discovery

Published

on


IntelliGen AI, an artificial intelligence (AI) start-up founded in Hong Kong, is positioning itself as a competitor to Google DeepMind in the field of drug discovery, as the city increasingly seeks to bolster its AI capabilities.

In an interview with the Post, founder and president Ronald Sun expressed confidence that IntelliGen AI could soon compete globally with Isomorphic Labs, a spin-off of DeepMind, in leveraging AI for drug screening and design.

“For generative science, new breakthroughs and application opportunities are global in nature,” Sun said. “Within 12 to 18 months, we aim to land major, high-value clients on a par with Isomorphic.”

The term “generative science”, although not widely recognised yet, refers to the use of AI to model the natural world and facilitate scientific discovery.

Ronald Sun, founder and president of IntelliGen AI. Photo: Handout

The company’s ambitious plan follows the launch of its IntFold foundational model, which is designed to predict the three-dimensional structures of biomolecules, including proteins. The model’s accuracy levels were comparable to DeepMind’s AlphaFold 3, according to IntelliGen AI.



Source link

Continue Reading

AI Research

Hong Kong start-up IntelliGen AI aims to challenge Google DeepMind in drug discovery

Published

on


IntelliGen AI, an artificial intelligence (AI) start-up founded in Hong Kong, is positioning itself as a competitor to Google DeepMind in the field of drug discovery, as the city increasingly seeks to bolster its AI capabilities.

In an interview with the Post, founder and president Ronald Sun expressed confidence that IntelliGen AI could soon compete globally with Isomorphic Labs, a spin-off of DeepMind, in leveraging AI for drug screening and design.

“For generative science, new breakthroughs and application opportunities are global in nature,” Sun said. “Within 12 to 18 months, we aim to land major, high-value clients on a par with Isomorphic.”

The term “generative science”, although not widely recognised yet, refers to the use of AI to model the natural world and facilitate scientific discovery.

Ronald Sun, founder and president of IntelliGen AI. Photo: Handout

The company’s ambitious plan follows the launch of its IntFold foundational model, which is designed to predict the three-dimensional structures of biomolecules, including proteins. The model’s accuracy levels were comparable to DeepMind’s AlphaFold 3, according to IntelliGen AI.



Source link

Continue Reading

AI Research

July: Bristol AI partnership with France | News and features

Published

on


A new and unique supercomputing collaboration between the UK and France was announced at the UK-France Summit today (10 July).

As two of the most advanced countries in the development and use of AI for science, industry and public services, this partnership will significantly strengthen both countries’ national AI ecosystems and the wider European AI ecosystem.

The Bristol Centre for Supercomputing (BriCS) based at the University of Bristol and the Grand équipement national de calcul intensif (GENCI) will work on building and establishing a collaboration on supercomputing for the benefit of their respective communities and the broader European research ecosystem.

This joint initiative will foster bilateral scientific collaborations in the field of AI-specialisation across materials science, life sciences and medical, cybersecurity, AI security and safety, energy, and engineering, and more globally in AI for science.

The collaboration will ensure sharing of best practice on industrial involvement as well as establishing joint training and education tracks, exchange of students and researchers, hackathons, and the organisation of joint scientific seminars.

Both parties will collaborate in assessing new scientific and technical approaches including federated/distributed learning, agentic and frugal (cost efficient) AI, as well as jointly developed gathering and analysing information about advancements and trends in AI hardware and software. 

Professor Simon McIntosh-Smith, Director of the Bristol Centre for Supercomputing, said: “We are delighted to work alongside GENCI to deliver an innovative and productive European supercomputing ecosystem. Our AI supercomputer, Isambard-AI, is the 11th fastest and 4th greenest supercomputer in the world and having delivered on this project successfully and at pace, the BriCS team is perfectly positioned to co-lead this with the GENCI team.”

Professor Evelyn Welch, Vice-Chancellor and President of the University of Bristol, said: “The University of Bristol is proud to have forged this pioneering new European partnership that will enable unique collaboration with our French colleagues. We will continue to develop and grow the UK’s AI and supercomputing strategy alongside the Government, accelerating critical research and supporting industry innovations at home and internationally.”

A Letter of intention between BriCS and GENCI (PDF, 309kB) provides further information on the ambitions of the partnership.

Further information

About Isambard-AI

Isambard-AI is set to become the UK’s fastest and most powerful supercomputer, purpose-built for AI research following build completion in Summer 2025. Designed to provide open-source intelligence, it will transform research and drive AI-led breakthroughs in critical areas like automated drug discovery and climate research. 



Source link

Continue Reading

Trending